Sanuwave Health ROE 2012-2025 | SNWV
Current and historical return on equity (ROE) values for Sanuwave Health (SNWV) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Sanuwave Health ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-09-30 | $-0.01B | $0.00B | 66.67% |
| 2025-06-30 | $-0.04B | $-0.02B | 148.57% |
| 2025-03-31 | $-0.03B | $-0.02B | 101.54% |
| 2024-12-31 | $-0.03B | $-0.01B | 79.50% |
| 2024-09-30 | $0.00B | $-0.06B | 2.09% |
| 2024-06-30 | $0.00B | $-0.04B | 8.12% |
| 2024-03-31 | $-0.02B | $-0.05B | 33.03% |
| 2023-12-31 | $-0.03B | $-0.04B | 46.43% |
| 2023-09-30 | $-0.05B | $-0.07B | 90.09% |
| 2023-06-30 | $-0.03B | $-0.06B | 57.14% |
| 2023-03-31 | $-0.02B | $-0.05B | 44.44% |
| 2022-12-31 | $-0.01B | $-0.04B | 27.59% |
| 2022-09-30 | $-0.01B | $-0.03B | 36.36% |
| 2022-06-30 | $-0.02B | $-0.03B | 45.71% |
| 2022-03-31 | $-0.03B | $-0.04B | 82.44% |
| 2021-12-31 | $-0.03B | $-0.04B | 97.30% |
| 2021-09-30 | $-0.03B | $-0.03B | 139.53% |
| 2021-06-30 | $-0.04B | $-0.03B | 240.00% |
| 2021-03-31 | $-0.03B | $-0.02B | 247.27% |
| 2020-12-31 | $-0.03B | $-0.01B | 250.98% |
| 2020-09-30 | $-0.02B | $-0.01B | 195.74% |
| 2020-06-30 | $-0.01B | $-0.02B | 101.96% |
| 2020-03-31 | $-0.01B | $-0.01B | 92.31% |
| 2019-12-31 | $-0.01B | $-0.01B | 80.00% |
| 2019-09-30 | $-0.01B | $-0.01B | 66.67% |
| 2019-06-30 | $-0.01B | $-0.02B | 53.33% |
| 2019-03-31 | $-0.01B | $-0.02B | 54.24% |
| 2018-12-31 | $-0.01B | $-0.02B | 84.21% |
| 2018-09-30 | $-0.01B | $-0.01B | 100.00% |
| 2018-06-30 | $-0.01B | $-0.02B | 108.33% |
| 2018-03-31 | $-0.01B | $-0.01B | 107.32% |
| 2017-12-31 | $-0.01B | $-0.01B | 58.82% |
| 2017-09-30 | $0.00B | $-0.01B | 51.61% |
| 2017-06-30 | $0.00B | $-0.01B | 57.14% |
| 2017-03-31 | $0.00B | $-0.01B | 61.54% |
| 2016-12-31 | $-0.01B | $-0.01B | 100.00% |
| 2016-09-30 | $-0.01B | $-0.01B | 86.96% |
| 2016-06-30 | $-0.01B | $-0.01B | 90.91% |
| 2016-03-31 | $-0.01B | $-0.01B | 120.00% |
| 2015-12-31 | $-0.01B | $-0.01B | 111.11% |
| 2015-09-30 | $0.00B | $-0.01B | 114.29% |
| 2015-06-30 | $0.00B | $0.00B | 177.78% |
| 2015-03-31 | $0.00B | $0.00B | 400.00% |
| 2014-12-31 | $-0.01B | $0.00B | -2400.00% |
| 2014-09-30 | $-0.01B | $0.00B | 933.33% |
| 2014-06-30 | $-0.01B | $0.00B | 444.44% |
| 2014-03-31 | $-0.01B | $0.00B | 163.64% |
| 2013-12-31 | $-0.01B | $-0.01B | 125.71% |
| 2013-09-30 | $-0.01B | $-0.01B | 133.33% |
| 2013-06-30 | $-0.01B | $-0.01B | 100.00% |
| 2013-03-31 | $-0.01B | $-0.01B | 128.57% |
| 2012-12-31 | $-0.01B | $-0.01B | 120.00% |
| 2012-09-30 | $-0.01B | $-0.01B | 160.00% |
| 2012-06-30 | $-0.01B | $0.00B | 311.11% |
| 2012-03-31 | $-0.01B | $0.00B | 1333.33% |
| 2011-12-31 | $-0.01B | $0.00B | 444.44% |
| 2011-09-30 | $-0.02B | $0.00B | 333.33% |
| 2011-06-30 | $-0.02B | $0.00B | 206.45% |
| 2011-03-31 | $-0.02B | $-0.01B | 136.36% |
| 2010-12-31 | $-0.02B | $-0.01B | 148.84% |
| 2010-09-30 | $-0.01B | $-0.01B | 126.32% |
| 2010-06-30 | $-0.01B | $-0.01B | 165.52% |
| 2010-03-31 | $-0.01B | $-0.01B | 177.78% |
| 2009-12-31 | $-0.01B | $-0.01B | 280.00% |
| 2009-09-30 | $-0.01B | $0.00B | 628.57% |
| 2009-06-30 | $-0.01B | $0.00B | 1333.33% |
| 2009-03-31 | $-0.01B | $0.00B | 1466.67% |
| 2008-12-31 | $-0.01B | $0.00B | 1200.00% |
| 2008-09-30 | $0.00B | $0.00B | 0.00% |
| 2008-06-30 | $0.00B | $0.00B | 0.00% |
| 2008-03-31 | $0.00B | $0.00B | 0.00% |
| 2007-12-31 | $0.00B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.221B | $0.033B |
| SANUWAVE Health, Inc. is engaged in the development and commercialization of non-invasive, biological response-activating devices for the repair and regeneration of tissue, musculoskeletal and vascular structures. The Company's product candidates include its proprietary PACE technology applicable in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions; and dermaPACE for treatment of the skin and subcutaneous soft tissue. The Company's products help in activating biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. SANUWAVE Health, Inc. is based in Alpharetta, USA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $195.241B | 21.80 |
| EssilorLuxottica (ESLOY) | France | $138.190B | 0.00 |
| Stryker (SYK) | United States | $138.078B | 26.49 |
| Medtronic (MDT) | Ireland | $130.022B | 18.01 |
| Boston Scientific (BSX) | United States | $110.071B | 24.34 |
| Medline (MDLN) | United States | $59.498B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.159B | 0.00 |
| ResMed (RMD) | United States | $38.392B | 25.64 |
| Agilent Technologies (A) | United States | $36.486B | 23.12 |
| GE HealthCare Technologies (GEHC) | United States | $36.105B | 17.30 |
| Koninklijke Philips (PHG) | Netherlands | $31.690B | 18.81 |
| Terumo (TRUMY) | Japan | $20.046B | 22.65 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.114B | 11.15 |
| Insulet (PODD) | United States | $17.756B | 55.11 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.032B | 0.00 |
| Baxter (BAX) | United States | $11.278B | 9.10 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.091B | 29.09 |
| Demant (WILYY) | Denmark | $6.264B | 0.00 |
| Envista Holdings (NVST) | United States | $4.961B | 25.14 |
| Lantheus Holdings (LNTH) | United States | $4.454B | 13.57 |
| BillionToOne (BLLN) | United States | $4.208B | 0.00 |
| ICU Medical (ICUI) | United States | $3.782B | 24.02 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.128B | 14.76 |
| Haemonetics (HAE) | United States | $2.763B | 12.09 |
| Neogen (NEOG) | United States | $2.334B | 51.10 |
| Phibro Animal Health (PAHC) | United States | $2.097B | 18.48 |
| LeMaitre Vascular (LMAT) | United States | $1.996B | 40.17 |
| QuidelOrtho (QDEL) | United States | $1.984B | 12.76 |
| Perrigo (PRGO) | Ireland | $1.980B | 4.96 |
| AtriCure (ATRC) | United States | $1.882B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.615B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.593B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.441B | 20.86 |
| Green Thumb Industries (GTBIF) | United States | $1.423B | 62.36 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.325B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $1.126B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.091B | 323.57 |
| InMode (INMD) | Israel | $0.924B | 10.15 |
| Tilray Brands (TLRY) | Canada | $0.912B | 0.00 |
| Valneva SE (VALN) | France | $0.846B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.798B | 0.00 |
| Omeros (OMER) | United States | $0.792B | 0.00 |
| CeriBell (CBLL) | United States | $0.771B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.593B | 14.15 |
| Brainsway (BWAY) | Israel | $0.457B | 77.83 |
| Verano Holdings (VRNO) | United States | $0.447B | 0.00 |
| Cerus (CERS) | United States | $0.428B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.402B | 0.00 |
| SNDL (SNDL) | Canada | $0.384B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.368B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.315B | 25.12 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Evolus (EOLS) | United States | $0.288B | 0.00 |
| Quanterix (QTRX) | United States | $0.286B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.227B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| High Tide (HITI) | Canada | $0.209B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.207B | 18.54 |
| Aurora Cannabis (ACB) | Canada | $0.202B | 59.33 |
| OraSure Technologies (OSUR) | United States | $0.202B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.200B | 0.00 |
| Organigram Global (OGI) | Canada | $0.188B | 0.00 |
| Accendra Health (ACH) | United States | $0.184B | 1.85 |
| Sanara MedTech (SMTI) | United States | $0.174B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.166B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.152B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.135B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.135B | 0.00 |
| Fonar (FONR) | United States | $0.116B | 16.86 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.104B | 0.00 |
| Biote (BTMD) | United States | $0.101B | 4.42 |
| Exagen (XGN) | United States | $0.079B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.50 |
| Sharps Technology (STSS) | United States | $0.049B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 29.92 |
| Veru (VERU) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.033B | 0.00 |
| United-Guardian (UG) | United States | $0.031B | 15.56 |
| Jin Medical (ZJYL) | China | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| INLIF (INLF) | China | $0.010B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Agape ATP (ATPC) | $0.003B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |